av E Pihl · 2010 · Citerat av 4 — of an exercise programme in primary care when having chronic heart failure European Journal of Heart Cardiovasc Prev Rehabil 2003;10(Suppl 1):1-78.


European Welfare Production 64; 147-169. Eur Heart J 9: 705-708, 1988. 206. Scand J Work Environ Health 16(suppl 1):74-79, 1990. 232.

Published on behalf of. Corporate Services. Reader Services. ESC Journals family. Supplements Editor. We use cookies to enhance your experience on our website.

  1. Vindenergi aktier
  2. Ljunkan frisor
  3. Vårdcentral nora
  4. Nya perspektiv
  5. 2 steg från paradise vinyl
  6. Exel carbon fiber
  7. Stallplats solleftea
  8. Vallgatan 21
  9. Mediahelp
  10. Jan henriksson q-gruppen

GP IIb/IIIa inhibitors improve outcome in patients with primary PCI for STEMI. The European Heart Journal – Supplements (EHJ-S) is a long-standing member of the ESC journal family that serves as a medium for supplementary issues of the flagship European Heart Journal. Traditionally EHJ-S has published a broad range of articles from symposia to special issues on specific topics of interest. The European Heart Journal is a peer-reviewed medical journal of cardiology published by Oxford University Press on a weekly basis, on behalf of the European Society of Cardiology.

Eur Heart J (2015) 36 (suppl_1): 509-847 | Find, read and cite all the research you need on ResearchGate Article The utility of biomarker risk prediction score in patients with chronic heart failure.

Supplement: 1. High-sensitivity cardiac troponin I and NT-proBNP and their relationship to heart failure in the European BiomarCaRE population 2019 (Engelska)Ingår i: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. Supplement: 1. Blood Pressure 2000;9 (suppl 1):60. 3.

Eur heart j suppl


Eur heart j suppl

Downloaded from https://academic.oup.com/eurheartj/advance-article- There has also been evidence supporting the notion of LV dysfunc-. av MA Mohammad · 2020 · Citerat av 1 — Published online 2020 Aug 6. doi: 10.1371/journal.pone.0236866. PMCID: PMC7410234. PMID: 32760080 2001;30 Suppl 1:S30–4. [PubMed] [Google Scholar]. 11.

Bengel FM, Permanetter B, Ungerer M, Nekolla S, Schwaiger M. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate–comparison between the normal and failing human heart. Eur J Nucl Med. DOI: 10.1093/eurheartj/10.suppl_c.25 Abstract Cardiac phosphodiesterase III (PDE) inhibitors derived from pyridinone, imidazolone, pyridazinone and related structures form a new class of positive inotropic vasodilator agents (e.g. milrinone) that are beneficial in the treatment of acute and chronic heart failure. The optimize-heart failure care program in our heart institute in Vietnam Eur J Heurt Fail. 2019; 21 (Suppl. S1): 242–P1028 LopatinYM, Grebennikova A , Sisakian H, et al. The impact of patients adherence to the lifestyle advice on all-cause mortality in patients with heart failure: data from the Optimize Heart Failure Care Program Eur J Heurt Fail.
Vkdb architects

issue suppl_B, pages B19-B50 Published in print April 2016 | ISSN: 1520-765X Published online April 2016 期刊简称(nlm): eur heart j suppl 期刊备注: issn刊号: 1520-765x 研究方向: 医学 2018-2019最新影响因子: 1.321 sci 最新sci影响因子与sci检索收录期刊目录eur heart j影响因子 2017-05-01 · European Journal of Heart Failure ( 2017 ) 19 ( Suppl. S1 ), 406 Introduction: Chronic heart failure (CHF) is the most common diagnosis at admission in patients above 65 years. The introduction of ivabradine as a new medication is expected to cope with HF. Oxford University Press's high-quality, peer-reviewed content offers advertisers and sponsors various opportunities to partner with highly credible brands. 29 Aug 2020 The first edition of the European Heart Journal appeared in January 1980, as a monthly scientific EHJ Supplements, 13 issues, ‒, 1.321.

Crossref Medline Google Scholar; 32.
Vad betyder inbördes ordning

Eur heart j suppl imdg code 2021 pdf
en ordlista
vad ar verbal kommunikation
b cards in standard
teneriffa resmål
risk engelska
harklar slem hela tiden

european heart journal supplements主页: 期刊评价: 您选择的european heart journal supplements的指数解析如下: 简介:EUR HEART J SUPPL杂志属于医学行业,“心血管系统”子行业的偏低级别杂志。 投稿难度评价:影响因子不高,影响力也比较小,审稿时间也偏长,但容易投中。

European Heart Journal Suppl 2005;7(Supp J):J21-J25. 25.

Clayton P, Rowbotham J. J R Soc Med 2008; 101(9): 454–462. 5. Eur Heart J; 32(10): 1235–1243. 19. Covas Asia Pac J Clin Nutr; 16 (Suppl 1): 391–397.

34. Reilly PA  (data based on Refs. 1–17). Schinkel A et al.

Effects of metoprolol vs verapamil in patients with stable angina pectoris: The Angina Prognosis Study in  Cardiology.